 | • レポートコード：QYR9ST04313 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の膠芽腫治療薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。膠芽腫治療薬の種類別には、VEGF / VEGFR阻害剤、アルキル化剤、その他抗腫瘍薬に、用途別には、病院、癌研究機関、長期介護センター、診断センターに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・膠芽腫治療薬の種類別市場規模：VEGF / VEGFR阻害剤、アルキル化剤、その他抗腫瘍薬 ・膠芽腫治療薬の用途別市場規模：病院、癌研究機関、長期介護センター、診断センター ・膠芽腫治療薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Arbor Pharms LLC.、Bristol-Myers Squibb Company、Emcure Pharmaceuticals Ltd.、F. Hoffmann-La Roche AG、Merck & Co.、Sandoz、Sigma-Tau Pharmaceuticals ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Glioblastoma also is known as glioblastoma multiforme, is a type of malignant brain tumor that develops from glial cells. It proliferates at a rapid rate and is difficult to cure however; the treatment drugs are often prescribed to ease the symptoms.In 2018, the global Glioblastoma Treatment Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Glioblastoma Treatment Drugs.
This study researches the market size of Glioblastoma Treatment Drugs, presents the global Glioblastoma Treatment Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Glioblastoma Treatment Drugs in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Glioblastoma Treatment Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
This report includes the following manufacturers; we can also add the other companies as you want.
Bristol-Myers Squibb Company
Emcure Pharmaceuticals Ltd.
F. Hoffmann-La Roche AG
Merck & Co.
Sandoz
Sigma-Tau Pharmaceuticals
…
Market Segment by Product Type
VEGF/VEGFR Inhibitor
Alkylating Agents
Miscellaneous Antineoplastic
Market Segment by Application
Hospital
Cancer Research Organization
Long Term Care Center
Diagnostic Centers
Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Glioblastoma Treatment Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Glioblastoma Treatment Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Glioblastoma Treatment Drugs are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Glioblastoma Treatment Drugs Market Size Growth Rate by Type
1.3.2 VEGF/VEGFR Inhibitor
1.3.3 Alkylating Agents
1.3.4 Miscellaneous Antineoplastic
1.4 Market Segment by Application
1.4.1 Global Glioblastoma Treatment Drugs Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Cancer Research Organization
1.4.4 Long Term Care Center
1.4.5 Diagnostic Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Glioblastoma Treatment Drugs Market Size
2.1.1 Global Glioblastoma Treatment Drugs Revenue 2014-2025
2.1.2 Global Glioblastoma Treatment Drugs Sales 2014-2025
2.2 Glioblastoma Treatment Drugs Growth Rate by Regions
2.2.1 Global Glioblastoma Treatment Drugs Sales by Regions 2014-2019
2.2.2 Global Glioblastoma Treatment Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Glioblastoma Treatment Drugs Sales by Manufacturers
3.1.1 Glioblastoma Treatment Drugs Sales by Manufacturers 2014-2019
3.1.2 Glioblastoma Treatment Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Glioblastoma Treatment Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Glioblastoma Treatment Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Glioblastoma Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Glioblastoma Treatment Drugs Price by Manufacturers
3.4 Key Manufacturers Glioblastoma Treatment Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Glioblastoma Treatment Drugs Market
3.6 Key Manufacturers Glioblastoma Treatment Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 VEGF/VEGFR Inhibitor Sales and Revenue (2014-2019)
4.1.2 Alkylating Agents Sales and Revenue (2014-2019)
4.1.3 Miscellaneous Antineoplastic Sales and Revenue (2014-2019)
4.2 Global Glioblastoma Treatment Drugs Sales Market Share by Type
4.3 Global Glioblastoma Treatment Drugs Revenue Market Share by Type
4.4 Glioblastoma Treatment Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.1 Global Glioblastoma Treatment Drugs Sales by Application
6 North America
6.1 North America Glioblastoma Treatment Drugs Breakdown Data by Company
6.2 North America Glioblastoma Treatment Drugs Breakdown Data by Type
6.3 North America Glioblastoma Treatment Drugs Breakdown Data by Application
6.4 North America Glioblastoma Treatment Drugs Breakdown Data by Countries
6.4.1 North America Glioblastoma Treatment Drugs Sales by Countries
6.4.2 North America Glioblastoma Treatment Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Glioblastoma Treatment Drugs Breakdown Data by Company
7.2 Europe Glioblastoma Treatment Drugs Breakdown Data by Type
7.3 Europe Glioblastoma Treatment Drugs Breakdown Data by Application
7.4 Europe Glioblastoma Treatment Drugs Breakdown Data by Countries
7.4.1 Europe Glioblastoma Treatment Drugs Sales by Countries
7.4.2 Europe Glioblastoma Treatment Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Glioblastoma Treatment Drugs Breakdown Data by Company
8.2 Asia Pacific Glioblastoma Treatment Drugs Breakdown Data by Type
8.3 Asia Pacific Glioblastoma Treatment Drugs Breakdown Data by Application
8.4 Asia Pacific Glioblastoma Treatment Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Glioblastoma Treatment Drugs Sales by Countries
8.4.2 Asia Pacific Glioblastoma Treatment Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Glioblastoma Treatment Drugs Breakdown Data by Company
9.2 Central & South America Glioblastoma Treatment Drugs Breakdown Data by Type
9.3 Central & South America Glioblastoma Treatment Drugs Breakdown Data by Application
9.4 Central & South America Glioblastoma Treatment Drugs Breakdown Data by Countries
9.4.1 Central & South America Glioblastoma Treatment Drugs Sales by Countries
9.4.2 Central & South America Glioblastoma Treatment Drugs Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Glioblastoma Treatment Drugs Breakdown Data by Type
10.2 Middle East and Africa Glioblastoma Treatment Drugs Breakdown Data by Application
10.3 Middle East and Africa Glioblastoma Treatment Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Glioblastoma Treatment Drugs Sales by Countries
10.3.2 Middle East and Africa Glioblastoma Treatment Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa
11 Company Profiles
11.1 Arbor Pharms LLC.
11.1.1 Arbor Pharms LLC. Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Glioblastoma Treatment Drugs
11.1.4 Glioblastoma Treatment Drugs Product Introduction
11.1.5 Arbor Pharms LLC. Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Glioblastoma Treatment Drugs
11.2.4 Glioblastoma Treatment Drugs Product Introduction
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Emcure Pharmaceuticals Ltd.
11.3.1 Emcure Pharmaceuticals Ltd. Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Glioblastoma Treatment Drugs
11.3.4 Glioblastoma Treatment Drugs Product Introduction
11.3.5 Emcure Pharmaceuticals Ltd. Recent Development
11.4 F. Hoffmann-La Roche AG
11.4.1 F. Hoffmann-La Roche AG Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Glioblastoma Treatment Drugs
11.4.4 Glioblastoma Treatment Drugs Product Introduction
11.4.5 F. Hoffmann-La Roche AG Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Glioblastoma Treatment Drugs
11.5.4 Glioblastoma Treatment Drugs Product Introduction
11.5.5 Merck & Co. Recent Development
11.6 Sandoz
11.6.1 Sandoz Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Glioblastoma Treatment Drugs
11.6.4 Glioblastoma Treatment Drugs Product Introduction
11.6.5 Sandoz Recent Development
11.7 Sigma-Tau Pharmaceuticals
11.7.1 Sigma-Tau Pharmaceuticals Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Glioblastoma Treatment Drugs
11.7.4 Glioblastoma Treatment Drugs Product Introduction
11.7.5 Sigma-Tau Pharmaceuticals Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Glioblastoma Treatment Drugs Sales Channels
12.2.2 Glioblastoma Treatment Drugs Distributors
12.3 Glioblastoma Treatment Drugs Customers
13 Market Forecast
13.1 Global Glioblastoma Treatment Drugs Sales and Revenue Forecast 2019-2025
13.2 Global Glioblastoma Treatment Drugs Sales Forecast by Type
13.3 Global Glioblastoma Treatment Drugs Sales Forecast by Application
13.4 Glioblastoma Treatment Drugs Forecast by Regions
13.4.1 Global Glioblastoma Treatment Drugs Sales Forecast by Regions 2019-2025
13.4.2 Global Glioblastoma Treatment Drugs Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Glioblastoma Treatment Drugs Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Glioblastoma Treatment Drugs Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Glioblastoma Treatment Drugs Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Glioblastoma Treatment Drugs Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Glioblastoma Treatment Drugs Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Glioblastoma Treatment Drugs Product Picture
Table Glioblastoma Treatment Drugs Key Market Segments
Table Major Manufacturers Glioblastoma Treatment Drugs Covered in This Report
Table Global Glioblastoma Treatment Drugs Market Size Growth Rate by Type 2019-2025 (K Tons) & (Million US$)
Figure Global Glioblastoma Treatment Drugs Sales Market Shar by Type 2014-2025
Figure VEGF/VEGFR Inhibitor Figures
Table Major Manufacturers of VEGF/VEGFR Inhibitor
Figure Alkylating Agents Figures
Table Major Manufacturers of Alkylating Agents
Figure Miscellaneous Antineoplastic Figures
Table Major Manufacturers of Miscellaneous Antineoplastic
Table Global Glioblastoma Treatment Drugs Market Share by Application 2019-2025 (K Tons)
Figure Hospital Use Case
Figure Cancer Research Organization Use Case
Figure Long Term Care Center Use Case
Figure Diagnostic Centers Use Case
Figure Glioblastoma Treatment Drugs Report Years Considered
Figure Global Glioblastoma Treatment Drugs Market Size 2014-2025 (Million US$)
Figure Global Glioblastoma Treatment Drugs Sales 2014-2019 (K Tons)
Table Global Glioblastoma Treatment Drugs Market Size by Regions 2014-2019 (K Tons) & (Million US$)
Table Global Glioblastoma Treatment Drugs Sales by Regions 2014-2019 (K Tons)
Table Global Glioblastoma Treatment Drugs Sales Market Share by Regions 2014-2019
Figure Global Glioblastoma Treatment Drugs Sales Market Share by Regions 2014-2019
Figure Global Glioblastoma Treatment Drugs Sales Market Share by Regions in 2018
Table Global Glioblastoma Treatment Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Glioblastoma Treatment Drugs Revenue Market Share by Regions 2014-2019
Figure Global Glioblastoma Treatment Drugs Revenue Market Share by Regions 2014-2019
Figure Global Glioblastoma Treatment Drugs Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Glioblastoma Treatment Drugs Sales by Manufacturers (2014-2019) (K Tons)
Table Global Glioblastoma Treatment Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Glioblastoma Treatment Drugs Sales Share by Manufacturers in 2018
Table Glioblastoma Treatment Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Glioblastoma Treatment Drugs Revenue Share by Manufacturers (2014-2019)
Figure Glioblastoma Treatment Drugs Value Share by Manufacturers in 2018
Table Global Glioblastoma Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Glioblastoma Treatment Drugs Price (2014-2019) (USD/Ton)
Table Key Manufacturers Glioblastoma Treatment Drugs Plants/Factories Distribution
Table Key Manufacturers Glioblastoma Treatment Drugs Area Served
Table Date of Key Manufacturers Enter into Glioblastoma Treatment Drugs Market
Table Key Manufacturers Glioblastoma Treatment Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global VEGF/VEGFR Inhibitor Sales an目录输出!D Revenue (2014-2019) (K Tons) & (Million US$)
Table Global Alkylating Agents Sales an目录输出!D Revenue (2014-2019) (K Tons) & (Million US$)
Table Global Miscellaneous Antineoplastic Sales an目录输出!D Revenue (2014-2019) (K Tons) & (Million US$)
Table Global Glioblastoma Treatment Drugs Sales by Type (2014-2019) (K Tons)
Table Global Glioblastoma Treatment Drugs Sales Share by Type (2014-2019)
Figure Global Glioblastoma Treatment Drugs Sales Market Share by Type (2014-2019)
Figure Global Glioblastoma Treatment Drugs Sales Market Share by Type in 2018
Table Global Glioblastoma Treatment Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Glioblastoma Treatment Drugs Revenue Share by Type (2014-2019)
Figure Global Glioblastoma Treatment Drugs Revenue Market Share by Type (2014-2019)
Figure Global Glioblastoma Treatment Drugs Revenue Market Share by Type in 2018
Table Glioblastoma Treatment Drugs Price by Type 2014-2019 (USD/Ton)
Table Global Glioblastoma Treatment Drugs Sales by Application (2014-2019) (K Tons)
Table Global Glioblastoma Treatment Drugs Sales Share by Application (2014-2019)
Figure Global Sales Glioblastoma Treatment Drugs Market Share by Application (2014-2019)
Figure Global Sales Glioblastoma Treatment Drugs Market Share by Application in 2018
Figure North America Glioblastoma Treatment Drugs Sales Growth Rate 2014-2019 (K Tons)
Figure North America Glioblastoma Treatment Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Glioblastoma Treatment Drugs Sales by Company (2014-2019) (K Tons)
Table North America Glioblastoma Treatment Drugs Sales Market Share by Company (2014-2019)
Figure North America Glioblastoma Treatment Drugs Sales Market Share by Company in 2018
Table North America Glioblastoma Treatment Drugs Sales by Type (2014-2019) (K Tons)
Table North America Glioblastoma Treatment Drugs Sales Market Share by Type (2014-2019)
Figure North America Glioblastoma Treatment Drugs Market Share by Type in 2018
Table North America Glioblastoma Treatment Drugs Sales by Application (2014-2019) (K Tons)
Table North America Glioblastoma Treatment Drugs Sales Market Share by Application (2014-2019)
Figure North America Glioblastoma Treatment Drugs Market Share by Application in 2018
Table North America Glioblastoma Treatment Drugs Sales by Countries (2014-2019) (K Tons)
Table North America Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Figure North America Glioblastoma Treatment Drugs Sales Market Share by Countries in 2018
Table North America Glioblastoma Treatment Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Glioblastoma Treatment Drugs Revenue Market Share by Countries in 2018
Figure United States Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Canada Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Mexico Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Europe Glioblastoma Treatment Drugs Sales Growth Rate 2014-2019 (K Tons)
Figure Europe Glioblastoma Treatment Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Glioblastoma Treatment Drugs Sales by Company (2014-2019) (K Tons)
Table Europe Glioblastoma Treatment Drugs Sales Market Share by Company (2014-2019)
Figure Europe Glioblastoma Treatment Drugs Sales Market Share by Company in 2018
Table Europe Glioblastoma Treatment Drugs Sales by Type (2014-2019) (K Tons)
Table Europe Glioblastoma Treatment Drugs Sales Market Share by Type (2014-2019)
Figure Europe Glioblastoma Treatment Drugs Sales Market Share by Type in 2018
Table Europe Glioblastoma Treatment Drugs Sales by Application (2014-2019) (K Tons)
Table Europe Glioblastoma Treatment Drugs Sales Market Share by Application (2014-2019)
Figure Europe Glioblastoma Treatment Drugs Sales Market Share by Application in 2018
Table Europe Glioblastoma Treatment Drugs Sales by Countries (2014-2019) (K Tons)
Table Europe Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Figure Europe Glioblastoma Treatment Drugs Sales Market Share by Countries in 2018
Table Europe Glioblastoma Treatment Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Glioblastoma Treatment Drugs Revenue Market Share by Countries in 2018
Figure Germany Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure France Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure UK Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Italy Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Russia Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Asia Pacific Glioblastoma Treatment Drugs Sales Growth Rate 2014-2019 (K Tons)
Figure Asia Pacific Glioblastoma Treatment Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Glioblastoma Treatment Drugs Sales by Regions (2014-2019) (K Tons)
Table Asia Pacific Glioblastoma Treatment Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Glioblastoma Treatment Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Glioblastoma Treatment Drugs Sales by Type (2014-2019) (K Tons)
Table Asia Pacific Glioblastoma Treatment Drugs Sales Market Share by Type (2014-2019)
Figure Asia Pacific Glioblastoma Treatment Drugs Market Share by Type in 2018
Table Asia Pacific Glioblastoma Treatment Drugs Sales by Application (2014-2019) (K Tons)
Table Asia Pacific Glioblastoma Treatment Drugs Sales Market Share by Application (2014-2019)
Figure Asia Pacific Glioblastoma Treatment Drugs Market Share by Application in 2018
Table Asia Pacific Glioblastoma Treatment Drugs Sales by Countries (2014-2019) (K Tons)
Table Asia Pacific Glioblastoma Treatment Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Glioblastoma Treatment Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Glioblastoma Treatment Drugs Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Glioblastoma Treatment Drugs Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Glioblastoma Treatment Drugs Revenue Market Share by Regions in 2018
Figure China Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure China Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Japan Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Korea Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure India Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Australia Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Indonesia Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Malaysia Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Philippines Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Thailand Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Vietnam Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Glioblastoma Treatment Drugs Sales Growth Rate 2014-2019 (K Tons)
Figure Central & South America Glioblastoma Treatment Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Glioblastoma Treatment Drugs Sales by Company (2014-2019) (K Tons)
Table Central & South America Glioblastoma Treatment Drugs Sales Market Share by Company (2014-2019)
Figure Central & South America Glioblastoma Treatment Drugs Sales Market Share by Company in 2018
Table Central & South America Glioblastoma Treatment Drugs Sales by Type (2014-2019) (K Tons)
Table Central & South America Glioblastoma Treatment Drugs Sales Market Share by Type (2014-2019)
Figure Central & South America Glioblastoma Treatment Drugs Market Share by Type in 2018
Table Central & South America Glioblastoma Treatment Drugs Sales by Application (2014-2019) (K Tons)
Table Central & South America Glioblastoma Treatment Drugs Sales Market Share by Application (2014-2019)
Figure Central & South America Glioblastoma Treatment Drugs Market Share by Application in 2018
Table Central & South America Glioblastoma Treatment Drugs Sales by Countries (2014-2019) (K Tons)
Table Central & South America Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Figure Central & South America Glioblastoma Treatment Drugs Sales Market Share by Countries in 2018
Table Central & South America Glioblastoma Treatment Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Central & South America Glioblastoma Treatment Drugs Revenue Market Share by Countries in 2018
Figure Brazil Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Brazil Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (K Tons)
Figure Middle East and Africa Glioblastoma Treatment Drugs Sales Growth Rate 2014-2019 (K Tons)
Figure Middle East and Africa Glioblastoma Treatment Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Glioblastoma Treatment Drugs Sales by Type (2014-2019) (K Tons)
Table Middle East and Africa Glioblastoma Treatment Drugs Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Glioblastoma Treatment Drugs Sales Market Share by Type in 2018
Table Middle East and Africa Glioblastoma Treatment Drugs Sales by Application (2014-2019) (K Tons)
Table Middle East and Africa Glioblastoma Treatment Drugs Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Glioblastoma Treatment Drugs Sales Market Share by Application in 2018
Table Middle East and Africa Glioblastoma Treatment Drugs Sales by Countries (2014-2019) (K Tons)
Table Middle East and Africa Glioblastoma Treatment Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Glioblastoma Treatment Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Glioblastoma Treatment Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Glioblastoma Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Glioblastoma Treatment Drugs Revenue Market Share by Countries in 2018
Figure GCC Countries Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure GCC Countries Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (K Tons)
Figure Egypt Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure Egypt Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (K Tons)
Figure South Africa Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019) (K Tons)
Figure South Africa Glioblastoma Treatment Drugs Revenue Growth Rate (2014-2019) (K Tons)
Table Arbor Pharms LLC. Company Details
Table Arbor Pharms LLC. Description and Business Overview
Table Arbor Pharms LLC. Glioblastoma Treatment Drugs Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Arbor Pharms LLC. Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019)
Table Arbor Pharms LLC. Glioblastoma Treatment Drugs Sales Market Share in Global Market
Table Arbor Pharms LLC. Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Description and Business Overview
Table Bristol-Myers Squibb Company Glioblastoma Treatment Drugs Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company Glioblastoma Treatment Drugs Sales Market Share in Global Market
Table Bristol-Myers Squibb Company Recent Development
Table Emcure Pharmaceuticals Ltd. Company Details
Table Emcure Pharmaceuticals Ltd. Description and Business Overview
Table Emcure Pharmaceuticals Ltd. Glioblastoma Treatment Drugs Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Emcure Pharmaceuticals Ltd. Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019)
Table Emcure Pharmaceuticals Ltd. Glioblastoma Treatment Drugs Sales Market Share in Global Market
Table Emcure Pharmaceuticals Ltd. Recent Development
Table F. Hoffmann-La Roche AG Company Details
Table F. Hoffmann-La Roche AG Description and Business Overview
Table F. Hoffmann-La Roche AG Glioblastoma Treatment Drugs Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche AG Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019)
Table F. Hoffmann-La Roche AG Glioblastoma Treatment Drugs Sales Market Share in Global Market
Table F. Hoffmann-La Roche AG Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Description and Business Overview
Table Merck & Co. Glioblastoma Treatment Drugs Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Merck & Co. Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019)
Table Merck & Co. Glioblastoma Treatment Drugs Sales Market Share in Global Market
Table Merck & Co. Recent Development
Table Sandoz Company Details
Table Sandoz Description and Business Overview
Table Sandoz Glioblastoma Treatment Drugs Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Sandoz Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019)
Table Sandoz Glioblastoma Treatment Drugs Sales Market Share in Global Market
Table Sandoz Recent Development
Table Sigma-Tau Pharmaceuticals Company Details
Table Sigma-Tau Pharmaceuticals Description and Business Overview
Table Sigma-Tau Pharmaceuticals Glioblastoma Treatment Drugs Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Sigma-Tau Pharmaceuticals Glioblastoma Treatment Drugs Sales Growth Rate (2014-2019)
Table Sigma-Tau Pharmaceuticals Glioblastoma Treatment Drugs Sales Market Share in Global Market
Table Sigma-Tau Pharmaceuticals Recent Development
Figure Glioblastoma Treatment Drugs Value Chain
Table Glioblastoma Treatment Drugs Distributors List
Table Glioblastoma Treatment Drugs Customers List
Table Global Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons) & (Million US$)
Figure Global Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Global Glioblastoma Treatment Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Glioblastoma Treatment Drugs Sales Forecast by Type 2019-2025 (K Tons)
Figure Global Glioblastoma Treatment Drugs Sales Forecast by Type 2019-2025 (K Tons)
Figure Global Glioblastoma Treatment Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Glioblastoma Treatment Drugs Sales Forecast by Application 2019-2025 (K Tons)
Figure Global Glioblastoma Treatment Drugs Sales Forecast by Application 2019-2025 (K Tons)
Figure Global Glioblastoma Treatment Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Glioblastoma Treatment Drugs Sales Forecast by Regions 2019-2025 (K Tons)
Figure Global Glioblastoma Treatment Drugs Sales Forecast by Regions 2019-2025 (K Tons)
Figure Global Glioblastoma Treatment Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Glioblastoma Treatment Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Glioblastoma Treatment Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Glioblastoma Treatment Drugs Revenue Market Share Forecast by Regions 2019-2025
Table North America Glioblastoma Treatment Drugs Sales Forecast by Countries 2019-2025 (K Tons)
Table North America Glioblastoma Treatment Drugs Sales Market Share Forecast by Countries 2019-2025
Table North America Glioblastoma Treatment Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Glioblastoma Treatment Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure United States Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Canada Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Mexico Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Table Europe Glioblastoma Treatment Drugs Sales Forecast by Countries 2019-2025 (K Tons)
Table Europe Glioblastoma Treatment Drugs Sales Market Share Forecast by Countries 2019-2025
Table Europe Glioblastoma Treatment Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Glioblastoma Treatment Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure France Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure UK Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Italy Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Russia Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Table Asia Pacific Glioblastoma Treatment Drugs Sales Forecast by Regions 2019-2025 (K Tons)
Table Asia Pacific Glioblastoma Treatment Drugs Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Glioblastoma Treatment Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Glioblastoma Treatment Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure China Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Japan Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure South Korea Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure India Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Australia Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Indonesia Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Thailand Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Malaysia Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Philippines Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Vietnam Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Table Central & South America Glioblastoma Treatment Drugs Sales Forecast by Countries 2019-2025 (K Tons)
Table Central & South America Glioblastoma Treatment Drugs Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Glioblastoma Treatment Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Glioblastoma Treatment Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Table Middle East and Africa Glioblastoma Treatment Drugs Sales Forecast by Regions 2019-2025 (K Tons)
Table Middle East and Africa Glioblastoma Treatment Drugs Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Glioblastoma Treatment Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Glioblastoma Treatment Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure GCC Countries Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure Egypt Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Figure South Africa Glioblastoma Treatment Drugs Sales Forecast 2019-2025 (K Tons)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測 Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. In 2018, the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was xx milli…- 再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測 Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. In 2018, the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was xx milli…
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 前立腺癌治療薬の世界市場：市場規模・現状・予測 Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players ar…